Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Rentokil Initial Broker Ratings



Broker Ratings for Rentokil Initial (RTO)


Share Price: 308.70Bid: 308.50Ask: 308.70Change: -2.10 (-0.68%)Faller - Rentokil Initl.
Spread: 0.20Spread as %: 0.06%Open: 311.20High: 312.20Low: 307.80Yesterday’s Close: 310.80


Broker Recommendations for Rentokil Initial (RTO)
DateBrokerRatingOld TargetNew TargetChange
04-Dec-17JefferiesHold-335.00New Coverage
18-Aug-17DeutscheBuy285.00330.00Reiteration
28-Jul-17JP Morgan CazenoveUnderweight194.00211.00Reiteration
10-Jul-17RBC Capital MarketsOutperform270.00300.00Reiteration
20-Apr-17JP Morgan CazenoveUnderweight185.00194.00Reiteration
03-Apr-17Numis SecuritiesAdd-270.00New Coverage
31-Mar-17Numis SecuritiesAdd-270.00Reiteration
13-Feb-17DeutscheBuy250.00260.00Reiteration
24-Oct-16Credit SuisseOutperform-255.00Reiteration
20-Oct-16JP Morgan CazenoveUnderweight155.00168.00Reiteration
13-Oct-16RBC Capital MarketsOutperform240.00260.00Downgrade
09-Aug-16Credit SuisseOutperform225.00235.00Reiteration
29-Jul-16DeutscheHold-160.00Reiteration
29-Jul-16JP Morgan CazenoveUnderweight-155.00Reiteration
18-Jul-16HSBCHold145.00190.00Upgrade


Registered members see more Rentokil Initial broker ratings!
Sign up here for your free account.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.